Fund Holdings — Affinity Asset Advisors, LLC

Total Portfolio Value:
$638.75M
Total Bought:
$163.30M
Total Sold:
$125.06M
Net Transaction:
+$38.24M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Xenon Pharmaceuticals Inc.(XENE)1,161,2371,328,175+166,938$45.52M$44.56M6.98%-$960.2K
Apogee Therapeutics Inc931,7281,151,199+219,471$42.21M$43.01M6.73%+$801.5K
Verona Pharma PlcADS660,000615,000-45,000$30.65M$39.05M6.11%+$8.40M
Arcellx Inc
COMMON STOCK
425,000530,000+105,000$32.59M$34.77M5.44%+$2.17M
Alkermes plcSHS(ALKS)1,100,0001,000,000-100,000$31.64M$33.02M5.17%+$1.38M
Nuvalent Inc285,000460,000+175,000$22.31M$32.62M5.11%+$10.31M
Madrigal Pharmaceuticals, Inc.(MDGL)82,50080,000-2,500$25.46M$26.50M4.15%+$1.04M
Centessa Pharmaceuticals PlcADS1,095,9241,546,662+450,738$18.36M$22.24M3.48%+$3.88M
Teva Pharmaceutical Industries LimitedADS(TEVA)1,400,0001,400,0000$30.86M$21.52M3.37%-$9.34M
Protagonist Therapeutics Inc130,000400,000+270,000$5.02M$19.34M3.03%+$14.33M
Travere Therapeutics, Inc.(TVTX)200,0001,070,000+870,000$3.48M$19.17M3.00%+$15.69M
Mineralys Therapeutics, Inc.(MLYS)350,0001,100,000+750,000$4.31M$17.47M2.73%+$13.16M
State Street SPDR S&P 500 ETF TrustTR UNIT(SPY)030,000+30,000$0$16.78M2.63%+$16.78M
Wave Life Sciences, Inc.SHS(WVE)1,500,0001,825,000+325,000$18.55M$14.75M2.31%-$3.81M
Omeros CorpNOTE 5 250 2 1000$14.61M$14.28M2.23%-$339.7K
Merus N V389,241321,962-67,279$16.37M$13.55M2.12%-$2.82M
Axsome Therapeutics, Inc.(AXSM)75,000100,000+25,000$6.35M$11.66M1.83%+$5.32M
Karyopharm Therapeutics IncNOTE 3 000 10 1000$11.87M$11.61M1.82%-$256.3K
Establishment Labs Holdings Inc.(ESTA)279,445280,000+555$12.87M$11.43M1.79%-$1.45M
Insmed Incorporated(INSM)50,000140,000+90,000$3.45M$10.68M1.67%+$7.23M
BridgeBio Pharma, Inc.(BBIO)200,000300,000+100,000$5.49M$10.37M1.62%+$4.88M
Nurix Therapeutics, Inc.(NRIX)940,083810,669-129,414$17.71M$9.63M1.51%-$8.08M
Vera Therapeutics, Inc.CL A(VERA)425,000355,143-69,857$17.97M$8.53M1.34%-$9.44M
Trevi Therapeutics, Inc.(TRVI)01,250,000+1,250,000$0$7.86M1.23%+$7.86M
Spyre Therapeutics, Inc.(SYRE)824,328481,678-342,650$19.19M$7.77M1.22%-$11.42M
Immunovant, Inc.(IMVT)100,000430,000+330,000$2.48M$7.35M1.15%+$4.87M
Travere Therapeutics, Inc.NOTE 2 250 3 0(TVTX)000$5.74M$6.99M1.09%+$1.25M
Newamsterdam Pharma Company
ORDINARY SHARES
425,000325,000-100,000$10.92M$6.65M1.04%-$4.27M
Oruka Therapeutics, Inc.(ORKA)368,698545,362+176,664$7.15M$5.60M0.88%-$1.55M
Neurocrine Biosciences, Inc.(NBIX)050,000+50,000$0$5.53M0.87%+$5.53M
Avalo Therapeutics, Inc.(AVTX)550,765657,154+106,389$4.09M$5.26M0.82%+$1.17M
Viridian Therapeutics, Inc.(VRDN)159,614390,000+230,386$3.06M$5.26M0.82%+$2.20M
Lexeo Therapeutics, Inc.(LXEO)01,480,881+1,480,881$0$5.14M0.80%+$5.14M
Crinetics Pharmaceuticals In460,000152,252-307,748$23.52M$5.11M0.80%-$18.41M
Rezolute, Inc.(RZLT)1,575,0001,700,000+125,000$7.72M$4.93M0.77%-$2.79M
Perspective Therapeutics, Inc.(CATX)1,300,0002,224,196+924,196$4.15M$4.74M0.74%+$590.5K
Autolus Therapeutics plcADS(AUTL)4,500,0003,045,000-1,455,000$10.57M$4.72M0.74%-$5.86M
Erasca, Inc.(ERAS)2,499,4313,341,519+842,088$6.27M$4.58M0.72%-$1.70M
Proqr Thrapeutics N VSHS EURO
SHS EURO
2,825,0003,284,512+459,512$7.49M$4.37M0.68%-$3.12M
uniQure N.V.SHS(QURE)0400,000+400,000$0$4.24M0.66%+$4.24M
Perceptive Cap Solutions CorCL A
CL A ORD SHS
350,000350,0000$3.56M$3.62M0.57%+$56.0K
Soleno Therapeutics Inc130,00050,000-80,000$5.84M$3.57M0.56%-$2.27M
Inozyme Pharma Inc3,972,3183,867,710-104,608$11.00M$3.52M0.55%-$7.48M
Akebia Therapeutics, Inc.(AKBA)01,500,000+1,500,000$0$2.88M0.45%+$2.88M
Maze Therapeutics, Inc.(MAZE)0250,000+250,000$0$2.75M0.43%+$2.75M
Newamsterdam Pharma CompanyW EXP 99 99 999
*W EXP 99/99/999
237,935241,957+4,022$3.33M$2.75M0.43%-$584.9K
Kymera Therapeutics, Inc.(KYMR)40,000100,000+60,000$1.61M$2.74M0.43%+$1.13M
Oaktree Acquisition Corp IiiUNIT 10 04 2029
UNIT 10/04/2029
250,000250,0000$2.54M$2.60M0.41%+$57.5K
Geron Corporation(GERN)2,250,0001,500,000-750,000$7.96M$2.38M0.37%-$5.58M
Monopar Therapeutics Inc.(MNPR)062,000+62,000$0$2.26M0.35%+$2.26M
Mirum Pharmaceuticals, Inc.(MIRM)70,74249,692-21,050$2.93M$2.24M0.35%-$686.6K
Aerovate Therapeutics Inc800,000800,0000$2.12M$2.01M0.31%-$112.0K
Cullinan Therapeutics, Inc.(CGEM)263,817263,8170$3.21M$2.00M0.31%-$1.22M
Climb Bio, Inc.(CLYM)500,0001,500,000+1,000,000$900.0K$1.83M0.29%+$930.0K
OnKure Therapeutics, Inc.CL A(OKUR)144,159394,159+250,000$1.24M$1.69M0.27%+$455.1K
Roivant Sciences Ltd.SHS(ROIV)0150,000+150,000$0$1.51M0.24%+$1.51M
Nkarta, Inc.(NKTX)800,000800,0000$1.99M$1.47M0.23%-$520.0K
Anteris Technologies Global Corp.(AVR)300,000390,000+90,000$1.67M$1.42M0.22%-$254.4K
MBX Biosciences, Inc.(MBX)0175,000+175,000$0$1.29M0.20%+$1.29M
Third Harmonic Bio Inc0370,000+370,000$0$1.28M0.20%+$1.28M
89bio Inc0175,000+175,000$0$1.27M0.20%+$1.27M
ABIVAX Société AnonymeADS(ABVX)0200,000+200,000$0$1.25M0.20%+$1.25M
Olema Oncology, Inc.(OLMA)0325,000+325,000$0$1.22M0.19%+$1.22M
Nextcure Inc2,302,5982,302,5980$1.78M$1.11M0.17%-$669.4K
MeiraGTx Holdings plc(MGTX)0150,000+150,000$0$1.02M0.16%+$1.02M
Vaxcyte, Inc.(PCVX)25,00025,0000$2.05M$944.0K0.15%-$1.10M
Viking Therapeutics, Inc.(VKTX)025,000+25,000$0$603.8K0.09%+$603.8K
Sutro Biopharma, Inc.(STRO)0752,722+752,722$0$489.7K0.08%+$489.7K
Context Therapeutics Inc.(CNTX)1,015,340660,589-354,751$1.07M$404.3K0.06%-$661.8K
Black Diamond Therapeutics I559,163250,000-309,163$1.20M$387.5K0.06%-$809.1K
Radiopharm Theranostics LimitedADS(RADX)156,17164,600-91,571$684.0K$310.7K0.05%-$373.3K
Zura Bio LimitedCL A(ZURA)223,335223,3350$558.3K$288.1K0.05%-$270.2K
Compass Therapeutics, Inc.(CMPX)0130,807+130,807$0$248.5K0.04%+$248.5K
Ovid Therapeutics Inc.(OVID)0667,516+667,516$0$208.2K0.03%+$208.2K
Repare Therapeutics Inc100,000200,000+100,000$131.0K$197.2K0.03%+$66.2K
Adagio Medical Holdings, Inc.(ADGM)213,235213,2350$223.9K$169.5K0.03%-$54.4K
Omeros Corporation(OMER)9,9589,9580$98.4K$81.9K0.01%-$16.5K
Allakos Inc0250,000+250,000$0$56.9K0.01%+$56.9K
Q32 Bio Inc.(QTTB)27,77727,7770$95.6K$45.8K0.01%-$49.7K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)75,00075,0000$2.6K$3.5K0.00%+$952
Immatics N.VW EXP 07 01 202187,204187,2040$47.1K$3.0K0.00%-$44.1K
Apellis Pharmaceuticals Inc
COM
50,0000-50,000$1.60M$0—-$1.60M
Arrowhead Pharmaceuticals, Inc.(ARWR)300,0000-300,000$5.64M$0—-$5.64M
Arvinas, Inc.(ARVN)630,0000-630,000$12.08M$0—-$12.08M
Celldex Therapeutics, Inc.(CLDX)9,9920-9,992$252.5K$0—-$252.5K
CG Oncology, Inc.(CGON)100,0000-100,000$2.87M$0—-$2.87M
Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS)000$16.19M$0—-$16.19M
COMPASS Pathways plcADS(CMPS)850,5120-850,512$3.21M$0—-$3.21M
Helix Acquisition Corp IiCL A250,0000-250,000$2.63M$0—-$2.63M
Inari Med Inc25,0000-25,000$1.28M$0—-$1.28M
Kezar Life Sciences Inc
COM NEW
142,3160-142,316$956.4K$0—-$956.4K
Rapt Therapeutics Inc1,000,0000-1,000,000$1.58M$0—-$1.58M
Savara Inc.(SVRA)410,5860-410,586$1.26M$0—-$1.26M
Syros Pharmaceuticals Inc150,0000-150,000$34.5K$0—-$34.5K
Tectonic Therapeutic, Inc.(TECX)58,3310-58,331$2.69M$0—-$2.69M
Page 1 of 1
Affinity Asset Advisors, LLC — 13F Holdings — Q1 2025 | TickerTrail